Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 21, 2017 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Reports Unfavorable Results of Phase 2 RADIANT Trial of CD101 Topical in VVC

Further Development of CD101 Topical for VVC to be discontinued CD101 IV development program in candidemia and invasive candidiasis (including Phase 2 STRIVE trial) continuing and remains on track ...
November 08, 2016 16:05 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the Stifel 2016 Healthcare Conference

SAN DIEGO, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced it will...
August 11, 2016 16:12 ET | Source: Cidara Therapeutics, Inc.

Cidara Reports Second Quarter 2016 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
July 05, 2016 07:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Expands Management Team

SAN DIEGO, July 05, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
May 12, 2016 17:12 ET | Source: Cidara Therapeutics, Inc.

Cidara Reports First Quarter 2016 Financial Results and Provides Corporate Update

SAN DIEGO, May 12, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
November 16, 2015 16:13 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Positive Data From Phase 1 Clinical Trial of CD101 IV and Reports Third Quarter 2015 Financial Results

-- Single Ascending Dose Study-Results Demonstrate Excellent Safety and Tolerability and Support Once-Weekly IV Dosing -- -- Management to Host Webcast and Conference Call Tomorrow at 8:00 a.m. ET...
November 10, 2015 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference in London

SAN DIEGO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...